logo

COYA

Coya Therapeutics·NASDAQ
--
--(--)
--
--(--)

COYA fundamentals

Coya Therapeutics (COYA) released its earnings on Aug 12, 2025: revenue was 163.62K (YoY -95.19%), missed estimates; EPS was -0.36 (YoY -89.47%), beat estimates.
Revenue / YoY
163.62K
-95.19%
EPS / YoY
-0.36
-89.47%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 11, 2025
Meeting link.
EPS
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.235-0.28-0.31-0.340.14-0.35-0.19-0.26-0.18-0.44-0.36
Forecast
-0.43-0.3202-0.35220.2573-0.3-0.17-0.3622-0.2754-0.1938-0.4187
Surprise
0.00%
+34.88%
+3.19%
+3.46%
-45.59%
-16.67%
-11.76%
+28.22%
+34.64%
-127.04%
+14.02%
Revenue
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--------6.00M100.00K3.40M01.00K300.00K163.62K
Forecast
--------7.50M--2.75M1.88M100.00K2.63M783.33K
Surprise
0.00%
0.00%
0.00%
0.00%
-19.99%
0.00%
+23.64%
-100.00%
-99.00%
-88.61%
-79.11%

Earnings Call